UNSPSC 51380000: Nonsteroidal anti inflammatory drugs NSAIDs

This classification codifies anti-inflammatory agents that are not steroids. in addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. they are used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation. they act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

UNSPSC 51380000 Nonsteroidal anti-inflammatory drugs NSAIDs is a Family code that, based on recent state and local procurement activity, does not reflect what is actually being solicited under this designation. Seminole County, Florida's recent IFB for naloxone and drug deactivation systems—posted June 30, 2026, with response due July 26, 2023—is plainly unrelated to the code's nominal scope of NSAIDs. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, but this procurement addresses opioid-reversal and drug-disposal infrastructure, not anti-inflammatory pharmaceuticals. The mismatch between the code's stated commodity and the work being tagged to it suggests the code sees little relevant recent activity in state and local procurement.

The single identified opportunity under this code does not support a meaningful characterization of issuing-body patterns, geographic concentration, or typical work streams. Naloxone procurement and drug deactivation system supply fall outside the Family code's intended scope, indicating either a data-taxonomy misalignment in the source system or an atypical use of this code. Business development professionals should verify whether relevant NSAIDs solicitations exist under alternative codes or commodity classifications, as the current Family code's recent-opportunities record does not reflect genuine anti-inflammatory drug purchasing activity by state and local governments.